Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype
{{output}}
Background: Sustained use of oral corticosteroids is associated with significant side effects. It is therefore of interest to find a corticosteroid-sparing agent. In two meta-analyses, methotrexate resulted in a rather small redu... ...
